Lexicon Pharmaceuticals to Present at Three Upcoming Investor Conferences

THE WOODLANDS, Texas, Sept. 01, 2026 /CourierPR/ -- Lexicon Pharmaceuticals, Inc., the biopharmaceutical company focused on pioneering medicines that transform patients' lives, will present at three upcoming investor conferences in New York, according to a recent announcement.

The company's management will participate in the Citi 2026 Biopharma Back to School Conference on September 9, 2026, from 11:20 to 11:55 AM Eastern Time. They will also present at the 2026 Cantor Global Healthcare Conference on September 10, 2026, from 3:20 to 3:50 PM Eastern Time, and at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026, from 9:00 to 9:30 AM Eastern Time. These presentations will provide insights into Lexicon's pipeline of drug candidates, currently in various stages of development.

The company's website also offers detailed information on its mission and current pipeline, which includes drug candidates for neuropathic pain, hypertrophic cardiomyopathy, obesity, and metabolic disorders.

Lexicon Pharmaceuticals aims to share updates and progress on its clinical and preclinical programs during these investor conferences, offering valuable insights to investors and stakeholders. The presentations will cover the latest advancements and potential future directions of the company's research efforts.